It's not so much being right or wrong, but raising awareness of the options. I agree with you and hope some deep pockets investors relieve the pressure on the PPS caused by the toxic loans.
Your point about the relative advantage of share buy back in the $.005 to $.01 range is well taken IMO. I hope whatever happens benefits both current and future shareholders of the company and enables rapid RegenMed progress on a firmer financial footing.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.